Profhilo® Body
The PROFHILO® injectables product line is based on stabilised hybrid cooperative complexes of hyaluronic acid, and it is the pioneer of BIOREMODELLING. It is the first product developed with NAHYCO® technology, a unique and innovative thermal production process, 100% free of chemical stabilising agents, patented by IBSA.
PROFHILO® BODY is indicated to support skin quality through its effects on skin hydration, elasticity, smoothness and skin laxity of the body.(1)
Both PROFHILO® and PROFHILO® BODY promote the restoration of firmness, tone and elasticity of skin tissue, and its use in any suitable affected areas supports its role in the remodelling of sagging skin.
PROFHILO® BODY (3.2% – 48 mg high molecular weight and 48 mg low molecular weight hyaluronic acid sodium salt)
1 pre-filled 3 ml syringe
2 Terumo needles 29G TW 12 mm
Reference:
1. PROFHILO® BODY Instructions for Use Leaflet.
PROFHILO® is a Class III medical device containing 16mg high molecular weight (MW) hyaluronic acid (HA) + 16mg low MW HA/1mL syringe that is obtained through a patented treatment (NAHYCO Hybrid Technology) which provides it with unique characteristics for its use in the face and body, where it is injected with an ultrafine needle to plump the skin to smooth away wrinkles and improve texture and skin quality. PROFHILO must only be administered by a trained healthcare professional. Treatment costs and normal doctor’s fees will apply. PROFHILO has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Do not inject into inflamed areas or intravenously or intramuscularly. Please consult your doctor regarding its suitability for you, or if there are any questions regarding precautions and side effects. For further product information, please refer to your doctor or the Instructions for Use leaflet at Dermocosmètica PTY LTD, Australia. PROFHILO is distributed in NZ by Healthcare Logistics, Auckland.
TAPS – BG3564
